When disaggregated by agreement type, the pattern becomes clear: quantitative, operationally robust triggers are concentrated almost exclusively in bilateral nuclear agreements (TTBT, PNE, START family). Non-nuclear biological and chemical weapons agreements (BWC, CWC, BDA) show no quantitative threshold triggers—they rely instead on state-party requests, post-declaration cycles, and circumstance-based mechanisms. This suggests nuclear distinctiveness is real and significant. But it's not universal across all nuclear agreements; it concentrates in bilateral superpower agreements. The biological and chemical weapons comparison reveals that this distinctiveness is not simply a function of the domain but of how major powers choose to structure bilateral negotiations.